Ergebnisse der randomisierten Phase-III-Studie der „German Testicular Cancer Study Group“-Reference-Cited by-同舟云学术

Ergebnisse der randomisierten Phase-III-Studie der „German Testicular Cancer Study Group“

Published:2009-03-21 Issue:5 Volume:48 Page:523-528
ISSN:0340-2592
Container-title:Der Urologe
language:de
Short-container-title:Urologe

Author:

Hartmann M., ,Siener R.,Krege S.,Schmelz H.,Dieckmann K.-P.,Heidenreich A.,Kwasny P.,Pechoel M.,Lehmann J.,Kliesch S.,Köhrmann K.-U.,Fimmers R.,Weißbach L.,Loy V.,Wittekind C.,Albers P.

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00120-008-1927-7.pdf

Reference30 articles.

1. Albers P, Siener R, Kliesch S et al (2003) Risk factors for relapse in clinical stage I non-seminomatous testicular germ cell tumors: results of the German testicular cancer study group trial. J Clin Oncol 21: 1505–1512

2. Albers P, Siener R, Krege S et al (2008) Randomized phase III trial comparing retroperitoneal lymph node dissection with one course bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clincal stage I nonseminomatous testicular germ cell tumors: AUO trial 01/94 by the German testicular cancer study group. J Clin Oncol 26: 2966–2972

3. Baniel J, Foster RS, Rowland RG et al (1994) Complications of primary retroperitoneal lymph node dissection. J Urol 152: 424–427

4. Bokemeyer C, Berger CC, Kuczyk MA, Schmoll HJ (1996) Evaluation of long-term toxicity after chemotherapy for testicular cancer. J Clin Oncol 14: 2923–2932

5. Corti Ortiz D, Foneron Burgos A, Troncoso Schifferli L (1997) Treatment of stage I nonseminomatous testicular cancer with one cycle of adjuvant chemotherapy. Actas Urol Esp 21: 961–963

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hodentumor: Survivorship und Langzeittoxizität;Die Urologie;2023

2. Hodentumor: Survivorship und Langzeittoxizität;Die Urologie;2023

3. Radiotherapy role in non-seminomatous germ cell tumors, radiobiological and technical issues of an unexplored scenario;International Journal of Clinical Oncology;2021-07-17

4. Therapie des metastasierten Hodentumors;Die Urologie;2016

5. Hodentumor: Survivorship und Langzeittoxizität;Die Urologie;2016